GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Net Change in Cash

BioVaxys Technology (BioVaxys Technology) Net Change in Cash : $-0.27 Mil (TTM As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

BioVaxys Technology's Net Change in Cash for the three months ended in Jul. 2023 was $-0.02 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jul. 2023 was $-0.27 Mil.

BioVaxys Technology Net Change in Cash Historical Data

The historical data trend for BioVaxys Technology's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Net Change in Cash Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Net Change in Cash
- 0.16 1.66 -1.47 -0.33

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 -0.17 -0.05 -0.03 -0.02

BioVaxys Technology Net Change in Cash Calculation

BioVaxys Technology's Net Change in Cash for the fiscal year that ended in Oct. 2022 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-1.151+0+0.809+0.011
=-0.33

BioVaxys Technology's Net Change in Cash for the quarter that ended in Jul. 2023

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-0.018+0+0+-0.003
=-0.02

Net Change in Cash for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioVaxys Technology Net Change in Cash Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

BioVaxys Technology (BioVaxys Technology) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Net Change in Cash
Comparable Companies
XCNQ:NOVA XCNQ:GLOW XCNQ:BRAX XCNQ:MBIO TSX:APLI TSXV:IOT XCNQ:MESC TSXV:MRVL TSX:IPCI XCNQ:CMND OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
5LB:Germany BIOV:Canada
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
Website
https://www.biovaxys.com
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.